156 related articles for article (PubMed ID: 34975297)
21. PRMT5 regulates colorectal cancer cell growth and EMT via EGFR/Akt/GSK3β signaling cascades.
Yan Y; Zhao P; Wang Z; Liu Z; Wang Z; Zhang J; Ding Y; Hua X; Yu L
Aging (Albany NY); 2021 Jan; 13(3):4468-4481. PubMed ID: 33495409
[TBL] [Abstract][Full Text] [Related]
22. Tetraspanin 6 is a regulator of carcinogenesis in colorectal cancer.
Andrijes R; Hejmadi RK; Pugh M; Rajesh S; Novitskaya V; Ibrahim M; Overduin M; Tselepis C; Middleton GW; Győrffy B; Beggs AD; Berditchevski F
Proc Natl Acad Sci U S A; 2021 Sep; 118(39):. PubMed ID: 34521767
[TBL] [Abstract][Full Text] [Related]
23. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
Yang Z; Wu D; Chen Y; Min Z; Quan Y
Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
[TBL] [Abstract][Full Text] [Related]
24. 8‑Gingerol regulates colorectal cancer cell proliferation and migration through the EGFR/STAT/ERK pathway.
Hu SM; Yao XH; Hao YH; Pan AH; Zhou XW
Int J Oncol; 2020 Jan; 56(1):390-397. PubMed ID: 31814036
[TBL] [Abstract][Full Text] [Related]
25. Caveolin-1 Inhibits Proliferation, Migration, and Invasion of Human Colorectal Cancer Cells by Suppressing Phosphorylation of Epidermal Growth Factor Receptor.
Yang J; Zhu T; Zhao R; Gao D; Cui Y; Wang K; Guo Y
Med Sci Monit; 2018 Jan; 24():332-341. PubMed ID: 29339715
[TBL] [Abstract][Full Text] [Related]
26. Inhibitor of growth 4 suppresses colorectal cancer growth and invasion by inducing G1 arrest, inhibiting tumor angiogenesis and reversing epithelial-mesenchymal transition.
Qu H; Yin H; Yan S; Tao M; Xie Y; Chen W
Oncol Rep; 2016 May; 35(5):2927-35. PubMed ID: 26936485
[TBL] [Abstract][Full Text] [Related]
27. Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines.
Vitiello PP; Cardone C; Martini G; Ciardiello D; Belli V; Matrone N; Barra G; Napolitano S; Della Corte C; Turano M; Furia M; Troiani T; Morgillo F; De Vita F; Ciardiello F; Martinelli E
J Exp Clin Cancer Res; 2019 Jan; 38(1):41. PubMed ID: 30691487
[TBL] [Abstract][Full Text] [Related]
28. Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells.
Luo BH; Xiong F; Wang JP; Li JH; Zhong M; Liu QL; Luo GQ; Yang XJ; Xiao N; Xie B; Xiao H; Liu RJ; Dong CS; Wang KS; Wen JF
PLoS One; 2014; 9(6):e99922. PubMed ID: 24945379
[TBL] [Abstract][Full Text] [Related]
29. PEAK1, acting as a tumor promoter in colorectal cancer, is regulated by the EGFR/KRas signaling axis and miR-181d.
Huang L; Wen C; Yang X; Lou Q; Wang X; Che J; Chen J; Yang Z; Wu X; Huang M; Lan P; Wang L; Iwamoto A; Wang J; Liu H
Cell Death Dis; 2018 Feb; 9(3):271. PubMed ID: 29449544
[TBL] [Abstract][Full Text] [Related]
30. Circular RNA hsa_circRNA_102209 promotes the growth and metastasis of colorectal cancer through miR-761-mediated Ras and Rab interactor 1 signaling.
Li C; Zhou H
Cancer Med; 2020 Sep; 9(18):6710-6725. PubMed ID: 32706154
[TBL] [Abstract][Full Text] [Related]
31. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
Ding C; Li L; Yang T; Fan X; Wu G
BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
[TBL] [Abstract][Full Text] [Related]
32. Ligand-Independent Epidermal Growth Factor Receptor Overexpression Correlates with Poor Prognosis in Colorectal Cancer.
Yun S; Kwak Y; Nam SK; Seo AN; Oh HK; Kim DW; Kang SB; Lee HS
Cancer Res Treat; 2018 Oct; 50(4):1351-1361. PubMed ID: 29361822
[TBL] [Abstract][Full Text] [Related]
33. Cadmium promotes colorectal cancer metastasis through EGFR/Akt/mTOR signaling cascade and dynamics.
Sun M; Jiang Z; Gu P; Guo B; Li J; Cheng S; Ba Q; Wang H
Sci Total Environ; 2023 Nov; 899():165699. PubMed ID: 37495125
[TBL] [Abstract][Full Text] [Related]
34. Platelet-activating factor induces ovine fetal pulmonary venous smooth muscle cell proliferation: role of epidermal growth factor receptor transactivation.
Zhou W; Ibe BO; Raj JU
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2773-81. PubMed ID: 17322418
[TBL] [Abstract][Full Text] [Related]
35. Defensin alpha 6 (DEFA6) is a prognostic marker in colorectal cancer.
Jeong D; Kim H; Kim D; Ban S; Oh S; Ji S; Kang D; Lee H; Ahn TS; Kim HJ; Bae SB; Lee MS; Kim CJ; Kwon HY; Baek MJ
Cancer Biomark; 2019; 24(4):485-495. PubMed ID: 30932884
[TBL] [Abstract][Full Text] [Related]
36. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
37. Reduced Human α-defensin 6 in Noninflamed Jejunal Tissue of Patients with Crohn's Disease.
Hayashi R; Tsuchiya K; Fukushima K; Horita N; Hibiya S; Kitagaki K; Negi M; Itoh E; Akashi T; Eishi Y; Okada E; Araki A; Ohtsuka K; Fukuda S; Ohno H; Okamoto R; Nakamura T; Tanaka S; Chayama K; Watanabe M
Inflamm Bowel Dis; 2016 May; 22(5):1119-28. PubMed ID: 26891258
[TBL] [Abstract][Full Text] [Related]
38. Desmoglein 3 gene mediates epidermal growth factor/epidermal growth factor receptor signaling pathway involved in inflammatory response and immune function of anaphylactic rhinitis.
Ri H; Peiyan Z; Jianqi W; Yunteng Z; Gang L; Baoqing S
Biomed Pharmacother; 2019 Oct; 118():109214. PubMed ID: 31382129
[TBL] [Abstract][Full Text] [Related]
39. Human α-Defensin 6: A Small Peptide That Self-Assembles and Protects the Host by Entangling Microbes.
Chairatana P; Nolan EM
Acc Chem Res; 2017 Apr; 50(4):960-967. PubMed ID: 28296382
[TBL] [Abstract][Full Text] [Related]
40. TRPM7 deficiency suppresses cell proliferation, migration, and invasion in human colorectal cancer via regulation of epithelial-mesenchymal transition.
Su F; Wang BF; Zhang T; Hou XM; Feng MH
Cancer Biomark; 2019; 26(4):451-460. PubMed ID: 31640089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
